Abstract: One example of a method of managing battery usage by a wireless mobile communication device includes reading a start time, an end time, and other information, for each of a number of extents, and identifying one or more handovers, using the start time, end time, and other information, wherein the one or more handovers are handover activity. Next, the handover activity is compared to an allowable threshold, and a determination made as to when the number of idle mode handovers exceeds the allowable threshold. Finally, battery usage by the wireless mobile communication device is reduced by taking action to reduce the number of idle mode handovers that occur.

Abstract: Accurate measurements of the presence or absence of an analyte (e.g., MRSA) in a sample are provided. For example, the sample can be subjected to an activation reagent (potentially after an initial reagent has already been added), which can cause a flash signal that increases and then decreases over time. Signal data points can be measured from the flash signal using a detector. A quadratic regression function that fits the signal data points can be determined. An accuracy of the quadratic fit can be determined, as well as a signal-to-background ratio. A difference between a signal-to-background term and an accuracy term can be used as a score that is compared to a threshold to determine whether the analyte is present in the sample.

Abstract: In a wireless call between two mobile phones, metrics of conversational latency between the two parties determines a measure of Quality of Service (QoS) for the one or more carriers of real-time transport protocol RTP packets. Packages of metrics are collected at the two terminal devices, each of which may have an independent local clock. A Quality of Service estimation apparatus transforms metric packages into a pair of probability distribution functions for a plurality of real-time transport protocol packets between two endpoints. The offset between the two independent local clocks is determined or eliminated. A key performance indicator is determined for End-to-End RTP stream delay by transforming the timestamps associated with transmission and reception at user equipment hosting a QoS agent.

Abstract: Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e.g., anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e.g., cathode).

Abstract: A switch-operated therapeutic agent delivery device. Embodiments of the operated therapeutic agent delivery device my include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, following performance of both a digital switch validation test and an analog switch validation test. The switch operated therapeutic agent delivery device may have two parts, which are assembled by a user prior to use. These devices may be configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices may indirectly control and/or monitor the applied current without directly measuring from the cathode of the patient terminal.

Abstract: Accurate measurements of the presence or absence of an analyte (e.g., MRSA) in a sample are provided. For example, the sample can be subjected to an activation reagent (potentially after an initial reagent has already been added), which can cause a flash signal that increases and then decreases over time. Signal data points can be measured from the flash signal using a detector. A quadratic regression function that fits the signal data points can be determined. An accuracy of the quadratic fit can be determined, as well as a signal-to-background ratio. A difference between a signal-to-background term and an accuracy term can be used as a score that is compared to a threshold to determine whether the analyte is present in the sample.

Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.

Abstract: A switch operated therapeutic agent delivery device is described. The device comprises two parts, which are assembled by a user prior to use. A first part contains a power supply and circuitry for the device; and a second part comprises electrodes and reservoirs containing the therapeutic agent to be delivered. The action of combining the two parts of the device causes the two parts to be irreversibly coupled together, completes an electrical connection between the two parts, and closes one or more switches, thereby connecting a power source, such as a battery, into the device's circuitry, thereby powering the device on so that it is ready for use. The device can then be attached to a patient, who can operate the device by pressing a button in a proper sequence.

Abstract: One example of a method of managing battery usage by a wireless mobile communication device includes reading a start time, an end time, and other information, for each of a number of extents, and identifying one or more handovers, using the start time, end time, and other information, wherein the one or more handovers are handover activity. Next, the handover activity is compared to an allowable threshold, and a determination made as to when the number of idle mode handovers exceeds the allowable threshold. Finally, battery usage by the wireless mobile communication device is reduced by taking action to reduce the number of idle mode handovers that occur.

Abstract: A method detects misconfiguration of a wireless network which wastes battery power in mobile devices within a location area of the network. A data collection agent installed in a wireless device records and reports idle-mode handovers. An analytics circuit reads RF measurements and locations from these reports to suggest where handover zones may be optimized or IRAT cell resection parameters are defective. A mobile device may self-tune battery consumption by determining its individual location areas of high battery consumption; desensitizing itself to cell signal strength instability; and increasing its tenacity to a most recently used cell.

Abstract: A switch operated therapeutic agent delivery device is described. The device comprises two parts, which are assembled by a user prior to use. A first part contains a power supply and circuitry for the device; and a second part comprises electrodes and reservoirs containing the therapeutic agent to be delivered. The action of combining the two parts of the device causes the two parts to be irreversibly coupled together, completes an electrical connection between the two parts, and closes one or more switches, thereby connecting a power source, such as a battery, into the device's circuitry, thereby powering the device on so that it is ready for use. The device can then be attached to a patient, who can operate the device by pressing a button in a proper sequence.

Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.

Abstract: In a wireless call between two mobile phones, metrics of conversational latency between the two parties determines a measure of Quality of Service (QoS) for the one or more carriers of real-time transport protocol RTP packets. Packages of metrics are collected at the two terminal devices, each of which may have an independent local clock. A Quality of Service estimation apparatus transforms metric packages into a pair of probability distribution functions for a plurality of real-time transport protocol packets between two endpoints. The offset between the two independent local clocks is determined or eliminated. A key performance indicator is determined for End-to-End RTP stream delay by transforming the timestamps associated with transmission and reception at user equipment hosting a QoS agent.

Abstract: The present invention comprises a system, apparatus, and method for subscribing to indicia related to a user experience or a peripheral device, in an embodiment a broadband wireless modem, recording selected indicia, and forwarding them to a server on a network. The system comprises a server coupled to a plurality of user terminals through a network, to receive a set of indicia, an apparatus for controlling a baseband/broadband processor, and a program product comprising instructions to adapt a central processing unit to perform as follows. In an embodiment, connecting to a broadband/baseband processor comprising issuing commands, subscribing to receive indicia, determining a condition has occurred, recording a plurality of indicia, forwarding a set of indicia to a destination on the network. Indicia includes measurement values, state changes, event occurrences, user actions, activity and inactivity at time stamped milestones, and sequences and combinations of the above.

Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.

Abstract: Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e.g., anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e.g., cathode).

Abstract: A method detects misconfiguration of a wireless network which wastes battery power in mobile devices within a location area of the network. A data collection agent installed in a wireless device records and reports idle-mode handovers. An analytics circuit reads RF measurements and locations from these reports to suggest where handover zones may be optimized or IRAT cell resection parameters are defective. A mobile device may self-tune battery consumption by determining its individual location areas of high battery consumption; desensitizing itself to cell signal strength instability; and increasing its tenacity to a most recently used cell.

Abstract: A switch operated therapeutic agent delivery device is described. The device comprises two parts, which are assembled by a user prior to use. A first part contains a power supply and circuitry for the device; and a second part comprises electrodes and reservoirs containing the therapeutic agent to be delivered. The action of combining the two parts of the device causes the two parts to be irreversibly coupled together, completes an electrical connection between the two parts, and closes one or more switches, thereby connecting a power source, such as a battery, into the device's circuitry, thereby powering the device on so that it is ready for use. The device can then be attached to a patient, who can operate the device by pressing a button in a proper sequence.

Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.

Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.